BPS 2014 Proceedings

Boulder Peptide Symposium, 2014

Showcase

Brief 15 minute presentations from companies developing peptide therapeutics and related technologies. This rapid and compressed format is designed for quick introduction between symposium participants to new technologies, and companies. Each presentation is structured to highlight the value of the technology or therapeutic being offered and the business strategy.

John Gledhill

Lead Scientst
Longevity Biotech

Hybridtides – a new class of therapeutic

Les Stewart

President and CEO
SolaranRx

SolaranRx

Kenneth Gruber

CEO
Tensive Controls

oral, drugableâ€ peptides:

David Earp

CEO
Circle Pharma

Permeable macrocycle therapeutics

Brett Malone

CEO
Techulon

Techlon: effective delivery mechanisms for therapeutic applications

Vladimir Podust

Director of Analytical Chemistry
Amunix

XTEN-peptide and protein half-life extension

Peptides In the Clinic

Preclinical and Clinical Evidence for Peptide Utility in Treating Infectious Diseases

Teruna Siahaan

Professor
The University of Kansas

Controlling Autoimmune Diseases Using Bifunctional Peptide Inhibitors (BPI)

Mark McLaughlin

Senior Member
Moffitt Cancer Center

Discovery and Drug Development Progress for MTI-101, a Cyclic Beta-hairpin Peptidomimetic.

Lijuan Zhang

Senior Director R&D Innovation
Helix BioMedix

Dissection of Innate Immunity Peptides to Discover Novel Promising Therapeutics

Chengwei Wu

Scientist
Merck Research Laboratories

D-Template Assembled Trimeric Peptide Mimetics of the HIV-1 gp41 Pre-Hairpin Intermediate Induce D5-like Neutralizing Antibody Responses

Alison McDermott

Professor
University of Houston

Antimicrobial Peptides: Innate Defense Against Ocular Surface Pathogens

Stapled Peptides

Science and applications of constrained peptides, cyclic and stapled motifs

Julio Camarero

Professor
University of Southern California

Targeting Protein-Protein Interactions with Engineered Cyclotides

Jane Aldrich

Professor
Kansas University School of Pharmacy

Orally Active Macrocyclic Peptides as Analgesics and Potential Treatments for Drug Abuse

Scott Lokey

CSO
Circle Pharma

Beyond cyclosporine A: Charting Islands of Bioavailability Beyond the Rule of 5?

Jose Tlaxca

Scientist
MedImmune

Intranasal Delivery of Peptide Therapeutics: Challenges and Strategies

Oral Presentations in Scientific Sessions

The session topics for Scientific Program are Peptides in the Clinic, Drug Delivery, Chemistry of Complex Peptides, Spotlight on Discovery, and Peptide Showcase. Abstracts may be submitted via the Apply to Present page on the website. Submissions will be reviewed by the Scientific Advisory Board on a monthly basis and the speaker will be notified of a decision.

Presentation length: Format is 25-30 minutes slide presentation with 5-10 minutes for Q&A, with the exception of Peptide Showcase talks which are 10 minute slide presentations with 5 minutes for Q&A. Please confirm with your session chair to confirm the exact presentation length.

Invited Speakers: Speakers are requested to supply their presentation details 30 days after receiving an invitation to present.

Program Book Deadline: Final abstract and title must be provided no later than September 1st. No changes to the program are possible after this date.

Presentation Format: Oral presenters please provide your presentation slides to the A/V table on the day of your presentation.

Lodging: All speakers are requested to reserve their own room. Discount rates at the conference hotel are available until August 16th.

Registration: All speakers, excluding sponsored presentation speakers, receive a complimentary registration upon approval of the abstract.

Peptide Showcase Description

The Peptide Showcase is an opportunity for an individual or company to “showcase” new ideas, technology and pipeline assets. Priority shall be given to presentations from biotech and startup companies. Service providers and vendors are not eligible. Speakers in the session receive a complimentary event registration.

Posters

Posters can be presented on any topic relevant to peptides including original research, innovative products and technologies.

Eligibility- Any attendee (from academia, industry, biotech or vendor/sponsor) can present a poster. The presentation must contain original scientific thinking. To submit a poster go to the Submit a Poster link from the meeting menu. All submissions are reviewed on a rolling basis and will be notified of approval. September 1st is the last day to submit a poster abstract. Approved posters are published on the BPF website.

A 30 ” x 40″ board shall be provided with thumb tacks. Board will be on an easel and can be rotated for either landscape or portrait formats. Once you apply for a poster, you will get email confirmation that your poster was accepted. The poster session and number assignments will be emailed one week before the Symposium.

Poster boards shall be available for display from 8am to 8pm the day of your assigned poster session. See the program agenda for the poster session schedule.

Public Release

Every presentation at the Boulder Peptide Symposium is automatically recorded. Speakers are required to give consent for sharing of the presentation video with the peptide community.